Tremfya

Tremfya, by Janssen Biotech Inc., treats Psoriatic Arthritis and moderate-to-severe plaque psoriasis. It is a biologic therapy targeting interleukin-23 (IL-23) to reduce inflammation and control symptoms, administered via subcutaneous injection every eight weeks after initial doses.